77.95

2.54% -2.08

Disc Medicine Inc (IRON)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Disc Medicine Inc stock is traded at $77.95, with a volume of 284.93K. It is down -2.54% in the last 24 hours and up +1.29% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Previous Close:

$80.03

Open:

$79.5

24h Volume:

284.93K

Relative Volume:

0.55

Market Cap:

$2.99B

Revenue:

Net Income/Loss:

$-241.60M

P/E Ratio:

-11.78

EPS:

-6.6167

Net Cash Flow:

$-201.34M

1W Performance:

-3.64%

1M Performance:

+1.29%

6M Performance:

+17.07%

1Y Performance:

+30.77%

1-Day Range:

$77.51

$80.53

1-Week Range:

$77.51

$83.63

52-Week Range:

$40.00

$99.50

Disc Medicine Inc Stock (IRON) Company Profile

Name

Disc Medicine Inc

Sector

Healthcare (1086)

Industry

Biotechnology (605)

Phone

(617) 674-9274

Address

321 ARSENAL STREET, SUITE 101, WATERTOWN

Employee

155

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

IRON's Discussions on Twitter

Compare IRON vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRON Disc Medicine Inc	77.95	3.03B	0	-241.60M	-201.34M	-6.6167
VRTX Vertex Pharmaceuticals Inc	542.10	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	797.48	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,022.02	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	141.06	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.49	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Resumed	Stifel	Buy
Jul-21-25	Initiated	Truist	Buy
Jul-03-25	Resumed	Morgan Stanley	Overweight
Jun-11-25	Resumed	Raymond James	Strong Buy
Feb-27-25	Initiated	TD Cowen	Buy
Nov-05-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-04-24	Upgrade	Raymond James	Outperform → Strong Buy
Oct-23-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy
Jun-07-23	Initiated	H.C. Wainwright	Buy
May-17-23	Initiated	Raymond James	Outperform
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight
Apr-21-23	Initiated	Stifel	Buy
Apr-20-23	Initiated	Morgan Stanley	Overweight
Mar-23-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Disc Medicine Inc Stock (IRON) Latest News

Aug 21, 2026

Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm

Aug 21, 2026

Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn

Aug 21, 2026

Aug 20, 2026

Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade

Aug 20, 2026

Handelsbanken Fonder AB Buys Shares of 12,700 Disc Medicine, Inc. $IRON - MarketBeat

Aug 20, 2026

Aug 19, 2026

Disc (IRON) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Trading Move - vinanet.vn

Aug 19, 2026

Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com - Investing.com Australia

Aug 19, 2026

Disc Medicine CEO John Quisel sells $2.6m in shares - Investing.com

Aug 19, 2026

Aug 18, 2026

Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares - Bitget

Aug 18, 2026

Insider Selling: Disc Medicine (NASDAQ:IRON) CEO Sells 33,000 Shares of Stock - MarketBeat

Aug 18, 2026

Disc Medicine (IRON) CEO sells 33K shares under trading plan - Stock Titan

Aug 18, 2026

Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire

Aug 18, 2026

GSA Capital Partners LLP Takes $1.19 Million Position in Disc Medicine, Inc. $IRON - MarketBeat

Aug 18, 2026

Aug 17, 2026

Disc Medicine faces class action after FDA reje... - Pluang

Aug 17, 2026

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire

Aug 17, 2026

Disc Medicine (NASDAQ: IRON) insider to sell 33,000 shares via plan - Stock Titan

Aug 17, 2026

Aug 16, 2026

Disc Medicine (IRON) Pulls Back 1.46% to $78.84 as Shares Test Key Resistance ZoneExhaustion Gap - vinanet.vn

Aug 16, 2026

Aug 15, 2026

Disc Medicine (IRON) Slips 1.46% as Biotech Consolidates Near Key SupportCovered Call ETF - Vinanet

Aug 15, 2026

Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com Australia

Aug 15, 2026

Aug 14, 2026

Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares - MarketBeat

Aug 14, 2026

Disc Medicine COO Jonathan Yu sells $66,444 in shares - Investing.com

Aug 14, 2026

Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan - Stock Titan

Aug 14, 2026

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record

Aug 14, 2026

Aug 13, 2026

Sei Investments Co. Takes Position in Disc Medicine, Inc. $IRON - MarketBeat

Aug 13, 2026

Aug 11, 2026

FMR LLC Trims Disc Medicine Inc (IRON) Stake: A Strategic Reduction Amid Biotech Volatility - GuruFocus

Aug 11, 2026